£109.99

It has never been this cheap. We have no record of a lower price.

£110 today · cheaper than every other day in the last 3 months

Springer Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 20 days · 20 data points (no recent data)

Historical
Generating forecast…
£109.99 £104.49 £106.69 £108.89 £111.09 £113.29 £115.49 25 July 2026 29 July 2026 03 August 2026 08 August 2026 13 August 2026
View at Amazon ↗

Price data last checked 71 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 20 days • 1 price levels

Days at Price
20 days 0 5 10 15 20 £110 Days at Price

Price Analysis

Most common price: £110 (20 days, 100.0%)

Price range: £110 - £110

Price levels: 1 different prices over 20 days

Description

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia provides a comprehensive understanding of the recent molecular genetics of Chronic Myelogenous Leukemia (CML) and a characterization of the molecular targets for drug development. Included are therapeutic implications, diagnosis, and prognosis for understanding and facilitating daily practice in the management of patients with CML. Understanding of the pathogenesis and therapy of hematological malignancies such as CML has grown significantly in recent years. This development owe much to the progress in molecular biology and now makes a major contribution to diagnosis and to treatment that pharmacologically targets the molecular events of CML. Molecular targeting therapy with newly developed agents such as small molecules and antibodies for hematological malignancies are being discovered after years of research. Some of these, including tyrosine kinase inhibitors such as imatinib, nilotinib, and dasatinib, lead to increased survival rates and improved therapies. With the opinion leaders of basic and clinical research in the field as authors, this book reviews recent advances in the biology of CML.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)
98% match

CHRONIC MYELOID LEUKEMIA FROM DAILY MA: From Daily Management to Complicated Issues (Cancer Etiology, Diagnosis and Treatments)

£159.79 14 Aug 2026
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
98% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£109.08 11 Aug 2026
Chemotherapy for Leukemia: Novel Drugs and Treatment
98% match

Chemotherapy for Leukemia: Novel Drugs and Treatment

Springer

£95.88 24 Sep 2026
Acute Myelogenous Leukemia (Contemporary Hematology)
98% match

Acute Myelogenous Leukemia (Contemporary Hematology)

Humana

£164.16 14 Aug 2026
Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)
98% match

Chronic Myeloid Leukemia: Methods and Protocols: 1465 (Methods in Molecular Biology)

Humana

£84.99 26 Sep 2026
Advance in the Treatment of Pediatric Leukemia
98% match

Advance in the Treatment of Pediatric Leukemia

£59.48 12 Oct 2026
Leukemias
98% match

Leukemias

Springer

£76.42 02 Oct 2026
Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)
98% match

Chronic Lymphocytic Leukemia, An Issue of Hematology/Oncology Clinics of North America: Volume 35-4 (The Clinics: Internal Medicine, Volume 35-4)

Elsevier

£76.99 17 Sep 2026
Acute Myeloid Leukemia (Hematologic Malignancies)
98% match

Acute Myeloid Leukemia (Hematologic Malignancies)

Springer

£88.21 13 Aug 2026
The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)
98% match

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America (Volume 31-4) (The Clinics: Internal Medicine, Volume 31-4)

Elsevier

£69.11 24 Sep 2026
Acute Myelogenous Leukemia - Contemporary Hematology Guide
98% match

Acute Myelogenous Leukemia - Contemporary Hematology Guide

Humana

£65.94 06 Oct 2026
Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)
98% match

Myeloproliferative Neoplasms, An Issue of Hematology/Oncology Clinics of North America: Volume 35-2 (The Clinics: Internal Medicine, Volume 35-2)

Elsevier

£72.22 17 Sep 2026
Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)
98% match

Acute Myeloid Leukemia: Methods and Protocols: 1633 (Methods in Molecular Biology, 1633)

Humana

£95.74 01 Oct 2026
Acute Leukemias (Hematologic Malignancies)
97% match

Acute Leukemias (Hematologic Malignancies)

Springer

£103.69 19 Aug 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£121.64 19 Aug 2026
Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)
97% match

Molecular Aspects of Hematologic Malignancies: Diagnostic Tools and Clinical Applications (Principles and Practice)

Springer

£114.51 17 Oct 2026
Molecular Aspects of Hematologic Malignancies - Diagnostic Tools
97% match

Molecular Aspects of Hematologic Malignancies - Diagnostic Tools

Springer

£112.14 05 Oct 2026
Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics
97% match

Hematologic Malignancies: Case Studies in Cytogenetic and Molecular Genetics

Springer

£122.70 23 Sep 2026
Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)
97% match

Molecular Genetics and Therapy of Leukemia: 84 (Cancer Treatment and Research, 84)

Springer

£212.01 12 Aug 2026
Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics
97% match

Hematologic Cancers: Molecular Pathobiology to Targeted Therapeutics

Springer

£113.76 03 Oct 2026
Hematologic Malignancies: Acute Leukemias
97% match

Hematologic Malignancies: Acute Leukemias

Springer

£199.97 20 Oct 2026
Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)
97% match

Leukemia and Related Disorders: Integrated Treatment Approaches (Contemporary Hematology)

Humana

£80.67 21 Aug 2026
Childhood Leukemias (Cambridge Medicine (Hardcover))
97% match

Childhood Leukemias (Cambridge Medicine (Hardcover))

Cambridge University Press

£80.85 26 Sep 2026
Leukemia: Methods and Protocols (Volume 538) - Lab Research
97% match

Leukemia: Methods and Protocols (Volume 538) - Lab Research

Humana

£102.47 02 Oct 2026